Integrative Analysis of Proteomics and Transcriptomics Reveals Endothelin Receptor B as Novel Single Target and Identifies New Combinatorial Targets for Multiple Myeloma

Integrative Analysis of Proteomics and Transcriptomics Reveals Endothelin Receptor B as Novel Single Target and Identifies New Combinatorial Targets for Multiple Myeloma

Despite the recent introduction of next-generation immunotherapeutic agents, multiple myeloma (MM) remains incurable. New strategies targeting MM-specific antigens may result in a more effective therapy by preventing antigen escape, clonal evolution, and tumor resistance. In this work, we adapted an...

Full description

Bibliographic Details
Main Authors:	Margaux Lejeune, Murat Cem Köse, Mégane Jassin, Marie-Jia Gou, Amaury Herbet, Elodie Duray, Gaël Cobraiville, Jacques Foguenne, Didier Boquet, André Gothot, Yves Beguin, Marianne Fillet, Jo Caers
Format:	Article
Language:	English
Published:	Wiley 2023-07-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/HS9.0000000000000901

Similar Items

Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies
by: Margaux Lejeune, et al.
Published: (2020-05-01)

Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple Myeloma
by: Margaux Lejeune, et al.
Published: (2021-06-01)

Contribution of Capillary Zone Electrophoresis Hyphenated with Drift Tube Ion Mobility Mass Spectrometry as a Complementary Tool to Microfluidic Reversed Phase Liquid Chromatography for Antigen Discovery
by: Marie-Jia Gou, et al.
Published: (2022-11-01)

Potential of Single Pulse and Multiplexed Drift-Tube Ion Mobility Spectrometry Coupled to Micropillar Array Column for Proteomics Studies
by: Cindy Nix, et al.
Published: (2022-07-01)

A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma
by: Elodie Duray, et al.
Published: (2021-11-01)

Imatinib and nilotinib inhibit hematopoietic progenitor cell growth, but do not prevent adhesion, migration and engraftment of human cord blood CD34+ cells.
by: Ludovic Belle, et al.
Published: (2012-01-01)

Radiotheranostic Agents in Hematological Malignancies
by: Jo Caers, et al.
Published: (2022-07-01)

Loss of Stromal Galectin-1 Enhances Multiple Myeloma Development: Emphasis on a Role in Osteoclasts
by: Joséphine Muller, et al.
Published: (2019-02-01)

Blood Microsampling to Monitor Metabolic Profiles During Physical Exercise
by: Cindy Nix, et al.
Published: (2021-05-01)

Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure
by: Michael P Smith, et al.
Published: (2017-08-01)

The Endothelin Type A Receptor as a Potential Therapeutic Target in Preeclampsia
by: Bhavisha Bakrania, et al.
Published: (2017-02-01)

Angiotensin and Endothelin Receptor Structures With Implications for Signaling Regulation and Pharmacological Targeting
by: David Speck, et al.
Published: (2022-04-01)

Evidence for the endothelin system as an emerging therapeutic target for the treatment of chronic pain
by: Smith TP, et al.
Published: (2014-08-01)

Alterations of erythropoiesis in Covid-19 patients: prevalence of positive Coombs tests and iron metabolism
by: Léa Schmitz, et al.
Published: (2023-09-01)

Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?
by: Vasaikar, Suhas, et al.
Published: (2018)

Targeting the Endothelin-1 pathway to reduce invasion and chemoresistance in gallbladder cancer cells
by: Francisco Rodas, et al.
Published: (2023-12-01)

Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A
by: Eun-Ju Im, et al.
Published: (2019-03-01)

Kinetics of IL-7 and IL-15 levels after allogeneic peripheral blood stem cell transplantation following nonmyeloablative conditioning.
by: Muriel De Bock, et al.
Published: (2013-01-01)

Targeting sinonasal undifferentiated carcinoma with a combinatory immunotherapy approach
by: Austin T.K. Hoke, et al.
Published: (2024-06-01)

Systematic Identification of Combinatorial Drivers and Targets in Cancer Cell Lines
by: Tabchy, Adel, et al.
Published: (2013)

Analysis of Targeted and Combinatorial Approaches to Phage T7 Genome Generation
by: Mallet, Alex
Published: (2007)

Combinatorial mapping of modulatory targets: computational design & simulation
by: Thomas Richner, et al.
Published: (2023-01-01)

Systematic identification of combinatorial drivers and targets in cancer cell lines.
by: Adel Tabchy, et al.
Published: (2013-01-01)

Combinatory antitumor therapy by cascade targeting of a single drug
by: Aiyun Liu, et al.
Published: (2020-04-01)

Post-transplant cyclophosphamide prevents xenogeneic graft-versus-host disease while depleting proliferating regulatory T cells
by: Caroline Ritacco, et al.
Published: (2023-03-01)

Signaling Pathways in Cancer: Therapeutic Targets, Combinatorial Treatments, and New Developments
by: Hon Yan Kelvin Yip, et al.
Published: (2021-03-01)

Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors
by: Dia Roy, et al.
Published: (2023-10-01)

Correction: Systematic Identification of Combinatorial Drivers and Targets in Cancer Cell Lines
Published: (2013-01-01)

Microfluidic Platform for Combinatorial Synthesis and Optimization of Targeted Nanoparticles for Cancer Therapy
by: Valencia, Pedro M., et al.
Published: (2015)

Correction: Systematic Identification of Combinatorial Drivers and Targets in Cancer Cell Lines.
by: Adel Tabchy, et al.
Published: (2013-01-01)

Combinatorial gene targeting in primary human hematopoietic stem and progenitor cells
by: Alexandra Bäckström, et al.
Published: (2022-10-01)

Combinatorial targeting of multiple myeloma by complementing T cell engaging antibody fragments
by: Maria Geis, et al.
Published: (2021-01-01)

Expression of Endothelin-1, Endothelin Receptor-A, and Endothelin Receptor-B in facial melasma compared to adjacent skin
by: da Silva CN, et al.
Published: (2023-10-01)

Variable Drug-Target Exposure, Tumor Signatures, and Combinatorial Targeted Treatment: Approaches of Personalized Medicine in Breast Cancer
by: Werner Schroth, et al.
Published: (2022-06-01)

A combinatorial glycolipidomic approach to the identification of new molecular targets in autoimmune neuropathy
by: Willison, H, et al.
Published: (2009)

A combinatory genetic strategy for targeting neurogliaform neurons in the mouse basolateral amygdala
by: Attila Ozsvár, et al.
Published: (2024-02-01)

Analysis of combinatorial regulation: scaling of partnerships between regulators with the number of governed targets.
by: Nitin Bhardwaj, et al.
Published: (2010-05-01)

Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism.
by: Simone Kumstel, et al.
Published: (2022-01-01)

Drug‐grafted DNA as a novel chemogene for targeted combinatorial cancer therapy
by: Yuhe Liu, et al.
Published: (2022-04-01)

Hishot display--a new combinatorial display for obtaining target-recognizing peptides.
by: Shoutaro Tsuji, et al.
Published: (2013-01-01)